Answers are grounded in this paper and cite their sources.
The Global Antibiotic Research and Development Partnership (GARDP) brings together public and private partners to accelerate the development and global availability of new antibiotics to treat the most challenging drug-resistant bacterial infections. Established in 2016, GARDP's recently launched strategy sets out its ambitious aim to deliver five new treatments by 2025, focusing on sexually transmitted infections, sepsis in newborns, and infections in hospitalized adults and children.
No takes yet. Share an insight, caveat, or question.
Balasegaram et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: